Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2601 to 2650 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
skeletal muscle lim-protein 3 (slim 3) (lim-domain protein dral) (four and a half lim domains protein 2) (fhl-2). [source:swissprot;acc:q14192]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2445\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3633.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3754.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03353\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
skeletal muscle tropomodulin (sk-tmod) (tropomodulin 4). [source:swissprot;acc:q9nzq9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1046\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4757.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5198.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09279\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small edrk-rich factor 2. [source:refseq;acc:nm\_005770]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2947\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small glutamine rich protein with tetratricopeptide repeats 2. [source:refseq;acc:nm\_019072]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
512\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10807.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12338.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14167\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small glutamine-rich tetratricopeptide repeat-containing protein (vpu-binding protein) (ubp). [source:swissprot;acc:o43765]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
565\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10434.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11846.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1353\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small gtp-binding tumor suppressor 1. [source:refseq;acc:nm\_145173]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
705\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6912.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7734.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11897\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein associated protein n (snrnp-n) (sm protein n) (sm-n) (smn) (sm-d) (tissue-specific splicing protein). [source:swissprot;acc:p14648]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3004\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein associated proteins b and b' (snrnp-b) (sm protein b/b') (sm-b/sm-b') (smb/smb'). [source:swissprot;acc:p14678]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3012\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein e (snrnp-e) (sm protein e) (sm-e) (sme). [source:swissprot;acc:p08578]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
204\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4512.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5655.52\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.25339\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein f (snrnp-f) (sm protein f) (sm-f) (smf). [source:swissprot;acc:q15356]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
205\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d1 (snrnp core protein d1) (sm-d1) (sm-d autoantigen). [source:swissprot;acc:p13641]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
82\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4172.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5954.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42694\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d2 (snrnp core protein d2) (sm-d2). [source:swissprot;acc:p43330]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
141\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4405.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5782.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3125\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d3 (snrnp core protein d3) (sm-d3). [source:swissprot;acc:p43331]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
187\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4569.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5885.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.28807\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
small optic lobes homolog; small optic lobes, drosophila, homolog of. [source:refseq;acc:nm\_005632]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2172\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5825.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6126.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05169\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
smooth muscle cell lim protein (cysteine-rich protein 2) (crp2) (lim-only protein 5). [source:swissprot;acc:q16527]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2378\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3977.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3818.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04182\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
snare associated protein snapin. [source:refseq;acc:nm\_012437]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1198\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5721.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6217.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0867\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
snrna activating protein complex 50 kda subunit (snapc 50 kda subunit) (proximal sequence element-binding transcription factor beta subunit) (pse-binding factor beta subunit) (ptf beta subunit). [source:swissprot;acc:q92966]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2849\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sodium-dependent multivitamin transporter (na(+)-dependent multivitamin transporter). [source:swissprot;acc:q9y289]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1167\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6607.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7186.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08759\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sodium/iodide cotransporter (na(+)/i(-) cotransporter) (sodium-iodide symporter) (na+/i-symporter). [source:swissprot;acc:q92911]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1164\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6600.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7178.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08764\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sodium/potassium-transporting atpase alpha-1 chain precursor (ec 3.6.3.9) (sodium pump 1) (na+/k+ atpase 1). [source:swissprot;acc:p05023]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2236\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5902.27\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6181.21\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04726\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
sodium/potassium-transporting atpase alpha-2 chain precursor (ec 3.6.3.9) (sodium pump 2) (na+/k+ atpase 2). [source:swissprot;acc:p50993]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2240\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
sodium/potassium-transporting atpase alpha-3 chain (ec 3.6.3.9) (sodium pump 3) (na+/k+ atpase 3) (alpha(iii)). [source:swissprot;acc:p13637]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2239\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
soluble liver antigen/liver pancreas antigen. [source:refseq;acc:nm\_153825]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1475\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5910.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6355.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0753\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 1 (renal sodium/sulfate cotransporter) (na(+)/sulfate cotransporter) (hnasi-1). [source:swissprot;acc:q9bzw2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1078\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.19\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09202\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 2 (renal sodium/dicarboxylate cotransporter) (na(+)/dicarboxylate cotransporter 1) (nadc-1). [source:swissprot;acc:q13183]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1079\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6439.66\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7032.22\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 3 (sodium-dependent high-affinity dicarboxylate transporter 2) (na(+)/dicarboxylate cotransporter 3) (nadc-3) (hnadc3). [source:swissprot;acc:q8wwt9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1077\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 13, member 4 (na+/sulfate cotransporter sut-1). [source:swissprot;acc:q9ukg4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1076\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6439.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7032.19\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 6 (glucose transporter type 6) (glucose transporter type 9). [source:swissprot;acc:q9ugq3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1991\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5429.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5749.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05902\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 8 (glucose transporter type 8) (glucose transporter type x1). [source:swissprot;acc:q9ny64]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1992\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 1; glvr-1; pit-1; gibbon ape leukemia virus receptor 1. [source:refseq;acc:nm\_005415]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1182\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4392.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4776.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08732\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 2; glvr-2; pit-2; gibbon ape leukemia virus receptor 2; murine leukemia virus, amphotropic; receptor. [source:refseq;acc:nm\_006749]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1179\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 21 member 15 (organic anion transporter polypeptide-related protein 4) (oatp-rp4) (oatprp4). [source:swissprot;acc:q9h2y9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2965\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 23, member 1 (sodium-dependent vitamin c transporter 1) (hsvct1) (na(+)/l-ascorbic acid transporter 1) (yolk sac permease-like molecule 3). [source:swissprot;acc:q9uhi7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1817\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 23, member 2 (sodium-dependent vitamin c transporter 2) (hsvct2) (na(+)/l-ascorbic acid transporter 2) (yolk sac permease-like molecule 2) (nucleobase transporter-like 1 protein). [source:swissprot;acc:q9ugh3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1831\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 27 (fatty acid transporter), member 4; fatty acid transport protein 4. [source:refseq;acc:nm\_005094]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2317\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6961.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7274.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04492\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 27 (fatty acid transporter), member 5; very long-chain acyl-coa synthetase homolog 2; very long-chain acyl-coa synthetase-related protein; likely ortholog of mouse solute carrier family 27 (fatty acid transporter), member 5. [source:refseq;acc:nm\_012254]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2315\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6961.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7273.85\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04493\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 27 member 3; fatty acid transport protein 3. [source:refseq;acc:nm\_024330]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2311\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6961.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7273.93\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 35, member b1; udp-galactose transporter related. [source:refseq;acc:nm\_005827]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2496\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5534.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5684.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0272\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 36 member 1; proton / amino acid symporter; lysosomal amino acid transporter 1. [source:refseq;acc:nm\_078483]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3026\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 4 (anion exchanger), member 1, adaptor protein; kidney anion exchanger adaptor protein; kanadaptin; lung cancer oncogene 3. [source:refseq;acc:nm\_018158]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
614\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11222.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9948.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12798\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
solute carrier family 5 (iodide transporter), member 8; apical iodide transporter. [source:refseq;acc:nm\_145913]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1166\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6606.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7185.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0876\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
son of sevenless protein homolog 1 (sos-1). [source:swissprot;acc:q07889]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1928\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7514.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7980.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06193\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
son of sevenless protein homolog 2 (sos-2). [source:swissprot;acc:q07890]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1905\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7497.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7967.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06257\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
son protein (son3) (negative regulatory element-binding protein) (nre- binding protein) (dbp-5) (bax antagonist selected in saccharomyces 1) (bass1) (protein c21orf50). [source:swissprot;acc:p18583]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
95\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2397.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3343.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.39481\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
442\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6251.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7192.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15038\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 1. [source:swissprot;acc:q13596]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2536\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5932.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6071.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02348\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 13 (rgs domain- and phox domain-containing protein) (rgs-px1). [source:swissprot;acc:q9y5w8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1972\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4374.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4126.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 16. [source:swissprot;acc:p57768]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3108\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 17. [source:swissprot;acc:q15036]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2551\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4725.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4824.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02087\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
sorting nexin 5. [source:swissprot;acc:q9y5x3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2741\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5339.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5327.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00234\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/